June 12 – 17, 2022
Continuous virus-like particle (VLP) production in insect cells with the baculo virus expression system faces numerous problems: The presence of defective interfering particles (DIPs) hinders continuous infection, cell growth is slower than virus replication, cell retention membranes and hollow fibres retain VLPs. High cell densities (HCD) can nevertheless enable VLP process intensification in small reactor vessels.
We were able to achieve a HCD with the Tnms42 insect cell line in both shaking flasks with pseudo perfusion and in the bioreactor utilizing an alternating tangential flow (ATF) filtration. Compared to some commercially available insect cell lines, this cell line has no persistent adventitious viral infection and is equally well suited to produce HA-GAG VLPs as HighFiveTM cells. With daily medium exchange the exponential growth phase could be elongated and the total cell concentration (TCC) increased by a factor of two in the shaking flask (SF) and four in the bioreactor (BR) to ~40x106 cells/mL in comparison to reference batch processes (~9 Figure 1). Such HCD can be used to optimize and investigate cell concentration at infection (CCI), multiplicity of infection (MOI) and cell state at infection to reach higher volumetric VLP titers.
Please click Download on the upper right corner to see the full abstract.
Lena Achleitner, Peter Satzer, and Alois Jungbauer, "High cell density culture for VLP production in latent virus-free insect cell line" in "Vaccine Technology VIII", Tarit Mukhopadhyay, Merck Research Laboratories, USA; Charles Lutsch, Sanofi Pasteur, France; Linda Hwee-Lin Lua, University of Queensland, Australia; Francesc Godia, Universitat Autònoma de Barcelona, Spain Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/vaccine_viii/86